Life Sciences & Pharmaceutical Research Feasibility
Life Sciences, Pharmaceutical, Cell Line, Medicinal Chemistry, Enzymology & In-Vivo Preclinical Research — Hyderabad & Pan-India
Discuss a research question with our Hyderabad team from anywhere in India. Cell-line studies are undertaken at Manna Biotech subject to method, model and instrument availability. Eligible in-vivo work may be coordinated under an MoU for execution at an external partner facility, subject to study-specific feasibility and approvals. Not every listed assay or model is automatically available.
- Scientist-guided, founder-led
- Research and industrial R&D
- Nacharam, Hyderabad · India-wide sample enquiries
Cell line studies & cellular toxicology
Discuss the cell model and endpoints before choosing an assay.
Cell-line studies are undertaken at Manna Biotech, subject to the specific cell line, method, expertise, instruments, controls and biosafety requirements being verified. A named endpoint is not a guarantee that the particular method or instrument is available.
Viability and phenotypic endpoints
Discuss cell line development and maintenance, MTT or SRB cell-viability assays, IC50 estimation, cell-based phenotypic assays and scratch wound healing. Controls and replicates must fit the model and question.
Apoptosis, ROS and DNA integrity
Review feasibility of apoptosis and reactive oxygen species (ROS) detection, DNA ladder assay and DNA fragmentation assay. The analytical method and interpretation limits require separate review.
Flow cytometry and confocal microscopy
Flow cytometry, FACS and confocal imaging require verification of the instrument, expertise and any external execution arrangement; their mention does not establish current in-house availability.
In-vivo preclinical & pharmacology
Define animal-study feasibility, approvals and execution responsibility.
Eligible in-vivo studies may be coordinated for execution at an external partner facility under an MoU, subject to verification of study-specific facility capability and applicable institutional, ethics and regulatory approvals. Manna Biotech does not claim to own an animal facility.
Potential efficacy questions
Discuss anticancer, anti-obesity, antidiabetic (including STZ, alloxan or high-fat diet), anti-inflammatory, immunomodulatory, antioxidant, analgesic, wound-healing, hepatoprotective, nephroprotective, cardioprotective and neurobehavioral research models, subject to external facility and model verification.
Safety and toxicology endpoints
Discuss proposed acute toxicity studies, including OECD 423 or 425 where appropriate, and separately scoped repeated-dose studies. The applicable guideline, study type, endpoint, laboratory status and acceptance must be confirmed. An OECD guideline number does not establish GLP or regulatory acceptance.
Associated study outputs
Hematology, biochemistry, histopathology and H&E staining, and PK/PD are separate scoping questions. Review the executing facility, specimen permissions, specialist capability and data handover before work is accepted.
Pharmacology, chemistry & natural products
Separate experimental feasibility from an accredited analytical claim.
Synthetic chemistry, specialist instruments and outsourced work are subject to a documented project-specific capability and commercial review.
Synthesis and natural products
Discuss synthetic route design and custom chemical synthesis, phytochemistry and natural product extraction, and silver, gold or polymeric nanoparticle synthesis where suitable facilities and materials can be verified.
Assay strategy
Review research-use in-vitro pharmacology, cell-based phenotypic screening and ADME-toxicity requirements, including the distinction between computational predictions and experimental assays.
Analytical characterization
HPLC, GC-MS, LC-MS, FTIR and UV-Vis can be discussed as requested methods; confirm access, validated method, sample compatibility, calibration, turnaround and reporting facility before commissioning.
Bioinformatics, cheminformatics & CADD
Scope the data, model and interpretation needed for the research question.
Computational approaches are research tools. Available software, data rights, licensing, analysis depth and feasibility are agreed for each scope.
Sequence and structure
Discuss sequence analysis, protein structure prediction, molecular modelling, molecular docking and molecular dynamics (MD) simulation with documented input data and chosen methods.
Drug-design methods
Assess QSAR studies, pharmacophore mapping, fragment-based drug designing (FBDD) and network pharmacology where the question, reference data and computational workflow are suitable.
Predicted properties and toxicity
Computational ADMET and TOPKAT toxicity prediction may be requested for feasibility review, subject to access, licensing and appropriate validation. Predictions are not clinical proof of safety or efficacy.
Molecular biology, biochemistry & enzymology
Review sample suitability, target and method before committing to outputs.
Nucleic acid methods
Discuss Oxford Nanopore WGS, 16S/ITS metagenomics, Sanger or amplicon sequencing, PCR, RT-PCR/qPCR, RNA extraction and purification, SNP-RFLP and DNA restriction fragment mapping. Methods and receiving requirements are confirmed for the sample.
Cloning, blots and hybridization
Gene cloning and subcloning, library screening, cDNA preparation or purification for microarrays, Northern blot, dot blot, slot blot, in-situ hybridization and reporter assays are proposed methods requiring facility and workflow verification.
Protein and enzymology
Discuss Western blot, recombinant protein expression and purification, SDS-PAGE gel electrophoresis, zymography, and biochemistry or enzymology kinetic assays with a defined target, matrix, controls and data handover.
Microbiology & immunology
Specify the organism, material and question to avoid overclaiming.
Antimicrobial endpoints
Discuss minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), zone of inhibition and biofilm inhibition studies for eligible organisms and materials.
Identity and immunological assays
Review microbial identification using appropriate 16S/ITS or biochemical approaches, and ELISA or other immunological assays, subject to target, method and facility fit.
Academic and industrial scope
Medical, PhD and dissertation enquiries can include authorised-data analysis and research mentoring. Scholars retain their own writing, interpretation and authorship; no fabricated results, sold authorship or guaranteed publication.
Research-grade scope and clear reporting boundaries.
Research-use feasibility does not establish clinical, diagnostic, GLP, NABL or statutory accreditation. In-vivo studies may be coordinated for execution at an external partner facility under an MoU, subject to verified study-specific capability and appropriate approvals; Manna does not claim to own an animal facility. Material transfer requires written acceptance and applicable biosafety and transport rules.
Sample suitability, the executing facility, method availability, biosafety, acceptance criteria and deliverables are confirmed in writing before work begins. We do not guarantee a particular result, publication, regulatory approval or commercial outcome.
Scientific leadership
Dr Chathyushya K B
Founder, MD & CEO — PhD Microbiology, ICMR-NIN; PGDM Bioinformatics; Advanced Diploma in Patent Law, NALSAR; 15+ years' scientific experience.
The scientific team reviews the question, sample plan and interpretation so that the report explains what the evidence supports and where further work is needed.
Read the founder's scientific profile →Plan your enquiry
Explore feasibility, timing and a quotation
Choose the closest options. This is a request for a review, not a confirmed service, price or completion date.
Loading choices. The website enquiry form remains available on this page.
Only enter your city and state. If provided, these are included in the prepared message; do not enter names, contact details or patient information here.
Estimated turnaround: Timing depends on the method, sample suitability, workload and reporting requirements. The team will confirm an estimate after review.
Next step: Share a non-confidential outline so the team can assess the question, requirements and next steps.
Methods, availability, fees, procurement and execution sites are confirmed for each project. In-vivo studies require applicable approvals and an authorised external partner facility under an MoU. Publication or admission is never guaranteed.
Share only a non-confidential outline initially. Do not include patient identifiers, unpublished protocols or sensitive sample details in WhatsApp. Request a suitable confidential channel before sharing them.
Select one option in each group to prepare your WhatsApp message. The website form is separate; please repeat the details there if you use it.
Request a service quotation
Start with the question your data must answer.
Share a non-confidential research objective, proposed method or endpoint, sample type and count, intended use and timeline. Do not include patient identifiers, confidential protocols or restricted material.
Choose the enquiry category that fits your request in the form, such as PhD, medical research, academic project or laboratory service.
Send a non-confidential outline first. Do not include patient identifiers or upload proprietary sequence data in this enquiry. Ask for an NDA and an approved transfer route when needed.
Nacharam, Hyderabad laboratory — approximately a 12-minute walk from Habsiguda Metro. Contact us before dispatching samples; collection, preservation and transport instructions depend on the approved assay.
Contract and bulk enquiries: +91 8977681985 · Technical scope: +91 8978792215
Related services
Choose the service that matches the scientific question.
Pan-India sample and remote research enquiries
Review written acceptance, lawful transport and feasible remote support before sending material.
In-vitro research feasibility
Discuss cell culture, microbiology and molecular research endpoints under a defined scope.
In-vivo research feasibility
Review external facility, model and approval requirements for proposed preclinical work.
Bioinformatics research services
Scope authorised data, sequencing analysis and computational research.
PhD and academic research mentoring
Plan author-led research with institutional and guide oversight.
Questions
Frequently asked questions
Does Manna Biotech offer every named method in-house?
+
No blanket claim is made. Cell-line studies are undertaken at Manna Biotech, subject to the required cell line, method and instrument availability. The team verifies staff, instruments, materials and execution capacity for each request; a separately verified specialist facility may be required or a request may not be accepted.
Can researchers and companies across India enquire?
+
Yes. Remote scoping is available for an initial non-confidential project outline. Physical sample intake is not automatic: the receiving facility must first confirm the material, method, permissions and carrier-approved transport conditions in writing.
Where are in-vivo studies performed?
+
Eligible in-vivo studies may be coordinated for execution at an external partner facility under an MoU after study-specific facility capability and applicable institutional, ethical and regulatory approvals are verified. Manna does not claim to own an animal facility; neither approval nor a model is guaranteed.
Can you confirm flow cytometry, confocal imaging, ADME or LC-MS for my project?
+
These are advanced requirements that need separate equipment, expertise, licensing where relevant, method and facility verification. Provide the non-confidential endpoint, model, sample type and required outputs. We will confirm whether the work is feasible in-house, needs a verified external facility, or cannot be accepted.
Are results clinical, accredited or guaranteed?
+
Research-use findings are not patient diagnosis, a clinical decision, a GLP claim or an accredited statutory report. An accredited or regulated use needs a separately verified facility with the correct scope. No result, publication, regulatory approval or commercial outcome is guaranteed.
How are academic writing, patents and confidential information handled?
+
The scholar and supervisor retain academic ownership, interpretation and authorship. We do not ghostwrite, fabricate data or sell authorship. Patent filing and prosecution require a qualified registered professional. Send only a non-confidential outline first; discuss an NDA, authorised data transfer and ownership terms before sharing sensitive material.